{"entity":{"type":"insider","cik":"0001766952","url":"/insider/0001766952","json_url":"/insider/0001766952.json","name":"Artal Treasury Ltd","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":7,"n_filings":6,"first":"2020-06-18","last":"2021-08-03","span_basis":"filed_date"},"name_variants":[{"name":"Artal Treasury Ltd","source":"filing","n_filings":6,"first_seen":"2020-06-18","last_seen":"2021-08-03"}],"transactions":[{"id":5431584,"accession":"0000899243-21-031304","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-21-031304","line_url":"/filing/0000899243-21-031304#line-3","is_derivative":false,"issuer_cik":"0001053906","issuer_name":"Omega Therapeutics, Inc.","issuer_ticker":"OMGA","issuer_name_source":null,"issuer_url":"/issuer/0001053906","owner_cik":null,"owner_name":"Westend S.A.; Stichting Administratiekantoor Westend; Invus Public Equities, L.P.; Invus Public Equities Advisors, LLC; Wittouck Amaury; Artal International Management S.A.; Artal International S.C.A.; Artal Group S.A.; Artal Treasury Ltd","owner_display_name":"Westend S.A.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":875000.0,"shares_display":"875,000","price_per_share":17.0,"price_display":"17.00","price_state":"stated","total_value":14875000.0,"total_display":"14,875,000.00","total_whole":"14,875,000","shares_owned_after":2273530.0,"shares_owned_after_display":"2,273,530","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-03","filed_date":"2021-08-03","scope":"insider"},{"id":5431579,"accession":"0000899243-21-031304","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-21-031304","line_url":"/filing/0000899243-21-031304#line-1","is_derivative":false,"issuer_cik":"0001053906","issuer_name":"Omega Therapeutics, Inc.","issuer_ticker":"OMGA","issuer_name_source":null,"issuer_url":"/issuer/0001053906","owner_cik":null,"owner_name":"Westend S.A.; Stichting Administratiekantoor Westend; Invus Public Equities, L.P.; Invus Public Equities Advisors, LLC; Wittouck Amaury; Artal International Management S.A.; Artal International S.C.A.; Artal Group S.A.; Artal Treasury Ltd","owner_display_name":"Westend S.A.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":75000.0,"shares_display":"75,000","price_per_share":16.1379,"price_display":"16.14","price_state":"stated","total_value":1210342.5,"total_display":"1,210,342.50","total_whole":"1,210,343","shares_owned_after":75000.0,"shares_owned_after_display":"75,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-07-30","filed_date":"2021-08-03","scope":"insider"},{"id":4707537,"accession":"0000899243-21-004899","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-21-004899","line_url":"/filing/0000899243-21-004899#line-1","is_derivative":false,"issuer_cik":"0001053906","issuer_name":"Seer, Inc.","issuer_ticker":"SEER","issuer_name_source":null,"issuer_url":"/issuer/0001053906","owner_cik":null,"owner_name":"Artal Treasury Ltd; Artal International Management S.A.; Artal International S.C.A.; Artal Group S.A.; Invus Public Equities, L.P.; Wittouck Amaury; Invus Public Equities Advisors, LLC; Westend S.A.; Stichting Administratiekantoor Westend","owner_display_name":"Artal Treasury Ltd","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":252545.0,"shares_display":"252,545","price_per_share":64.153,"price_display":"64.15","price_state":"stated","total_value":16201519.385,"total_display":"16,201,519.38","total_whole":"16,201,519","shares_owned_after":5588366.0,"shares_owned_after_display":"5,588,366","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-01","filed_date":"2021-02-03","scope":"insider"},{"id":3204093,"accession":"0000899243-20-034268","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-20-034268","line_url":"/filing/0000899243-20-034268#line-1","is_derivative":false,"issuer_cik":"0001062822","issuer_name":"LEXICON PHARMACEUTICALS, INC.","issuer_ticker":"LXRX","issuer_name_source":null,"issuer_url":"/issuer/0001062822","owner_cik":null,"owner_name":"Invus Advisors, L.L.C.; Artal Treasury Ltd; Invus Public Equities Advisors, LLC; Invus, L.P.; Invus Public Equities, L.P.","owner_display_name":"Invus Advisors, L.L.C.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10937500.0,"shares_display":"10,937,500","price_per_share":3.2,"price_display":"3.20","price_state":"stated","total_value":35000000.0,"total_display":"35,000,000.00","total_whole":"35,000,000","shares_owned_after":32259461.0,"shares_owned_after_display":"32,259,461","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-12-16","filed_date":"2020-12-17","scope":"insider"},{"id":2117559,"accession":"0001628280-20-017346","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001628280-20-017346","line_url":"/filing/0001628280-20-017346#line-2","is_derivative":false,"issuer_cik":"0001053906","issuer_name":"Seer, Inc.","issuer_ticker":"SEER","issuer_name_source":null,"issuer_url":"/issuer/0001053906","owner_cik":null,"owner_name":"Artal Treasury Ltd; Invus Public Equities, L.P.; Artal Group S.A.; Artal International Management S.A.; Artal International S.C.A.; Minne Pascal; Invus Public Equities Advisors, LLC; Westend S.A.; Stichting Administratiekantoor Westend","owner_display_name":"Artal Treasury Ltd","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":790000.0,"shares_display":"790,000","price_per_share":19.0,"price_display":"19.00","price_state":"stated","total_value":15010000.0,"total_display":"15,010,000.00","total_whole":"15,010,000","shares_owned_after":5840911.0,"shares_owned_after_display":"5,840,911","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-08","filed_date":"2020-12-10","scope":"insider"},{"id":2288270,"accession":"0000899243-20-030316","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-20-030316","line_url":"/filing/0000899243-20-030316#line-2","is_derivative":false,"issuer_cik":"0001053906","issuer_name":"SQZ Biotechnologies Co","issuer_ticker":"SQZ","issuer_name_source":null,"issuer_url":"/issuer/0001053906","owner_cik":null,"owner_name":"Artal International S.C.A.; Artal Group S.A.; Artal Treasury Ltd; Stichting Administratiekantoor Westend; Westend S.A.; Invus Public Equities Advisors, LLC; Invus Public Equities, L.P.; Artal International Management S.A.; Minne Pascal","owner_display_name":"Artal International S.C.A.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":465000.0,"shares_display":"465,000","price_per_share":16.0,"price_display":"16.00","price_state":"stated","total_value":7440000.0,"total_display":"7,440,000.00","total_whole":"7,440,000","shares_owned_after":1606308.0,"shares_owned_after_display":"1,606,308","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-03","filed_date":"2020-11-03","scope":"insider"},{"id":2456226,"accession":"0000899243-20-017117","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-20-017117","line_url":"/filing/0000899243-20-017117#line-2","is_derivative":false,"issuer_cik":"0001053906","issuer_name":"Generation Bio Co.","issuer_ticker":"GBIO","issuer_name_source":null,"issuer_url":"/issuer/0001053906","owner_cik":null,"owner_name":"Artal Group S.A.; Artal Treasury Ltd; Artal International S.C.A.; Invus Public Equities Advisors, LLC; Invus Public Equities, L.P.; Minne Pascal; Artal International Management S.A.; Stichting Administratiekantoor Westend; Westend S.A.","owner_display_name":"Artal Group S.A.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":800000.0,"shares_display":"800,000","price_per_share":19.0,"price_display":"19.00","price_state":"stated","total_value":15200000.0,"total_display":"15,200,000.00","total_whole":"15,200,000","shares_owned_after":2814191.0,"shares_owned_after_display":"2,814,191","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-16","filed_date":"2020-06-18","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001850838","name":"Omega Therapeutics, Inc.","url":"/issuer/0001850838","role":"Ten percent owner","n_filings":1,"first_seen":"2021-08-03","last_seen":"2021-08-03"},{"type":"issuer","type_label":"ISSUER","cik":"0001726445","name":"Seer, Inc.","url":"/issuer/0001726445","role":"Ten percent owner","n_filings":2,"first_seen":"2020-12-10","last_seen":"2021-02-03"},{"type":"issuer","type_label":"ISSUER","cik":"0001062822","name":"LEXICON PHARMACEUTICALS, INC.","url":"/issuer/0001062822","role":"Director, Ten percent owner","n_filings":1,"first_seen":"2020-12-17","last_seen":"2020-12-17"},{"type":"issuer","type_label":"ISSUER","cik":"0001604477","name":"SQZ Biotechnologies Co","url":"/issuer/0001604477","role":"Ten percent owner","n_filings":1,"first_seen":"2020-11-03","last_seen":"2020-11-03"},{"type":"issuer","type_label":"ISSUER","cik":"0001733294","name":"Generation Bio Co.","url":"/issuer/0001733294","role":"Ten percent owner","n_filings":1,"first_seen":"2020-06-18","last_seen":"2020-06-18"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001766952","retrieved_at":"2026-08-25T02:24:43+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}